Winfield Associates’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,700
| Closed | -$205K | – | 155 |
|
|
2021
Q4 | $205K | Sell |
2,700
-1,350
| -33% | -$103K | 0.07% | 150 |
|
|
2021
Q3 | $453K | Sell |
4,050
-500
| -11% | -$55.9K | 0.17% | 106 |
|
|
2021
Q2 | $737K | Buy |
4,550
+300
| +7% | +$48.6K | 0.27% | 80 |
|
|
2021
Q1 | $518K | Buy |
4,250
+2,710
| +176% | +$330K | 0.21% | 90 |
|
|
2020
Q4 | $236K | Buy |
+1,540
| New | +$236K | 0.1% | 116 |
|